Does USTEKINUMAB Cause Myositis? 188 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Myositis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
188
Reports of Myositis with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
160
Deaths
172
Hospitalizations
How Dangerous Is Myositis From USTEKINUMAB?
Of the 188 reports, 160 (85.1%) resulted in death, 172 (91.5%) required hospitalization, and 160 (85.1%) were considered life-threatening.
Is Myositis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 188 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Myositis?
NIVOLUMAB (682)
PEMBROLIZUMAB (596)
ATORVASTATIN (448)
METHOTREXATE (418)
PREDNISONE (369)
RITUXIMAB (355)
ADALIMUMAB (344)
IPILIMUMAB (305)
ATEZOLIZUMAB (249)
INFLIXIMAB (249)
Which USTEKINUMAB Alternatives Have Lower Myositis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE